How to treat Colon cancer?

['Umviriza uru rupapuro']

None iyo kanseri yo mu muhogo ivurwa gute?

Hari uburyo butandukanye bwo kuvura kanseri y'uruti rw'umugongo, bivanye n'urugero iyo ndwara igeze n'ukuntu imeze.

Mu bundi buryo bwo kuvura bukunda gukoreshwa harimwo:

1. Ukubaga: Ubu ni bwo buryo bukoreshwa cane mu kuvura kanseri y'uruti rw'umugongo.

Uwo muganga aca akura mu nda iyo kanseri be n'utugingo ngengabuzima tuyikikuje.

Mu bihe bimwebimwe, hari n'aho bakura igice gitoyi c'amara atagwaye kiri ku ruhande rumwe rw'iyo kanseri.

2. Imiti bita chimiothérapie: Iyo miti ikoresha imiti yica utugingo ngengabuzima twa kanseri.

Iyo miti irashobora gutangwa imbere canke inyuma y'ukubagwa, canke igatangwa iri kumwe n'imiti irimwo imishwarara.

3. Imiti irimwo imishwarara: Iyo miti ikoresha imishwarara ikomeye cane kugira ngo yice utugingo ngengabuzima twa kanseri.

Gishobora gukoreshwa imbere canke inyuma y'ukubagwa, canke kigakoreshwa mu kuvura umuntu hakoreshejwe imiti.

4. Imiti irondera ico igenewe: Iyo miti ikoresha imiti irondera utunyabuzima dutandukanye dutuma utugingo ngengabuzima twa kanseri dukura tukongera tukakwiragira.

Akenshi ikoreshwa iri kumwe n'imiti bita chimiothérapie.

5. Imiti irwanya indwara: Iyo miti ifasha abasoda b'umubiri kumenya utugingo ngengabuzima twa kanseri no kudutera.

Akenshi ikoreshwa iri kumwe n'iyindi miti.

6. Kuvura indwara zidakira: Ubwo buryo bwo kuvura burondera kugabanya ibimenyetso no gutuma abarwayi barwaye kanseri y'uruti rw'umugongo igeze kure barushiriza kumererwa neza.

Muri ivyo harimwo ukuvura ububabare, imfungurwa n'ibindi.

Birahambaye ko uganira n'umuganga ibijanye n'uburyo bwiza kuruta ubundi bwo kuvura, kuko uburyo bwiza kuruta ubundi buvana n'ukuntu umurwayi amerewe.

['Ibitabu vyo muri Bibiliya']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Tu Z, Ma Y, Akers W, Achilefu S, Gu Y: Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy. J Cancer Res Clin Oncol. 2014, 140 (4): 623-32.

Kim YE, Kwon S, Wu G, Kim D, Park BK, Park JA, Choi KC, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model. Oncotarget. 2014, 5 (18): 8402-15.

Khan FA, Albalawi R, Pottoo FH: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment. Med Res Rev. 2022, 42 (1): 227-258.

Kwon S, Kim YE, Park JA, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model. BMB Rep. 2014, 47 (4): 215-20.

Viale PH: Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses. Oncol Nurs Forum. 2006, 33 (1): 81-90.

Ortiz R, Prados J, Melguizo C, Rama AR, Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H, Aranega A: Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells. Biomed Pharmacother. 2012, 66 (7): 563-7.

['Urupapuro rwemeza ko ata ruhusha:']

["Uru rubuga rw'ivy'ubuvuzi ruratangwa ku bw'inyigisho no ku bw'ukumenyesha amakuru gusa, ntirutanga impanuro mu vy'ubuvuzi canke ngo rube urwego rw'abahinga mu vy'ubuvuzi."]

["Amakuru atangwa n'ivyo binyamakuru ntabereye gukoreshwa mu gusuzuma canke mu kuvura ingorane y'amagara canke indwara kanaka, kandi abarondera impanuro zijanye n'ivy'ubuvuzi bakwiye kwitura umuganga abifitiye uruhusha."]

["Urabona ko ubuhinga bwa none butanga inyishu z'ibibazo usanga butarimwo ukuri na canecane igihe ari ibitigiri, nk'akarorero igitigiri c'abantu barwaye indwara kanaka."]

["Niwame usaba impanuro umuganga wawe canke uwundi muntu abifitiye uburenganzira mu bijanye n'amagara yawe. Ntiwigere wirengagiza impanuro z'umuganga canke ngo ureke kuzirondera kubera ivyo wasomye kuri uyu muhora. Nimba wibaza ko hari ikintu cihutirwa mu vy'amagara, nuce uhamagara 911 canke uje aho bavurira indembe hagufi."]

["Igabishwa: uburenganzira bw'abafise ivyo banditse"]

["Itegeko ryo mu 1998 ryerekeye uburenganzira umuntu afise mu vyo akoresha mu guhanahana amakuru (Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) ritanga uburenganzira ku bantu bafise uburenganzira bwo guhanahana amakuru babona ko ibintu vyerekanwa kuri Internet bihonyanga uburenganzira bwabo hisunzwe amategeko ya Leta Zunze Ubumwe za Amerika ajanye n'uburenganzira umuntu afise. "]

['Mu gihe wibaza ko hari ibintu canke ibikoresho vyabonetse ku rubuga rwacu canke ku mbuga zacu bibangamiye uburenganzira bwawe, wewe (canke uwukugenzura) urashobora kuturungikira ubutumwa busaba ko ivyo bintu canke ivyo bikoresho bikurwaho canke ko bitagisubira kuboneka. ']

['Amatangazo ategerezwa kurungikwa mu nyandiko hakoreshejwe ubutumwa bwa "email" (raba ahavuga ngo "Kwitaba" kugira ngo umenye aderese ya "email").']

["Itegeko rya DMCA risaba ko umenyesha ko hari uwugomba guhonyanga uburenganzira bwawe mu gutanga amakuru akurikira: (1) idondorwa ry'igikorwa gikingiwe n'amategeko kiriko kiragirizwa guhonyanga uburenganzira bwawe; (2) idondorwa ry'ibiri mu vyo bavuga ko bihonyanga uburenganzira bwawe be n'amakuru ahagije atuma dushobora kumenya aho biri; (3) amakuru y'ukuntu twokwifatanya nawe, harimwo aderese yawe, inomero za telefone n'ikete ryawe ryo kurungikiranira ubutumwa kuri internet; (4) ivyemeza ko wemera udakeka ko ivyo bintu biri mu buryo uriko uridodombera bitahawe uburenganzira n'uwabitunganije, canke uwubiserukira, canke n'itegeko iryo ari ryo ryose; "]

["(5) urwandiko rwanditswe n'uwatanze iyo notifica-tion, rwemeza ko amakuru ari muri iyo notifica-tion ari ay'ukuri kandi ko afise ububasha bwo gukurikirana ivy'uwo muntu avuga ko yahonyanze uburenganzira bwiwe; "]

["n' (6) umukono w'umuntu canke w'ubuhinga bwa elegitoronike w'uwuri n'ico kintu canke w'umuntu yahawe uburenganzira bwo gukora ku bw'uwo muntu. "]

['Kudashiramwo amakuru yose ari aho haruguru vyoshobora gutuma ivyo kwitwarira umuntu bicererwa.']

['Uwushobora kugufasha']

['Turakwinginze uturungikire ubutumwa kuri email ufise ikibazo / iciyumviro.']

How to treat colon cancer?

There are several ways to treat colon cancer, depending on the stage and severity of the disease.

Some common treatments include:

1. Surgery: This is the most common treatment for colon cancer.

The surgeon removes the cancerous part of the colon and nearby lymph nodes.

In some cases, a small part of the healthy colon on either side of the cancer may also be removed.

2. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given before or after surgery, or in combination with radiation therapy.

3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.

It can be used before or after surgery, or in combination with chemotherapy.

4. Targeted therapy: This treatment uses drugs that target specific molecules involved in the growth and spread of cancer cells.

It is often used in combination with chemotherapy.

5. Immunotherapy: This treatment helps the immune system to recognize and attack cancer cells.

It is often used in combination with other treatments.

6. Palliative care: This type of care focuses on relieving symptoms and improving the quality of life for patients with advanced colon cancer.

It may include pain management, nutritional support, and emotional support.

It is important to discuss the best treatment options with a healthcare professional, as the most effective approach will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.